ShareCompartir
Volume 18, Number 7—July 2012
Research
Enterococcus faecalis Clones in Poultry and in Humans with Urinary Tract Infections, Vietnam
Louise Ladefoged Poulsen, Magne Bisgaard, Nguyen Thai Son, Nguyen Vu Trung, Hoang Manh An, and Anders Dalsgaard
Table 2
Antimicrobial drug susceptibility (MIC) testing of Enterococcus faecalis isolated from humans with urinary tract infections and poultry in the same household, Vietnam, January 2008–January 2010*
| Strain | Antimicrobial drug and test interval, µg/mL |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| CHL, 2–64 | DAP, 0.25–16 | ERY, 0.5–32 | GEN, 16–1,024 | KAN, 128–2,048 | MXF, 0.25–8 | STR, 64–2048 | Q-D, 0.25–16 | TET, 1–32 | |
| 90U | 64 | 4† | >32 | >1,024 | >2,048 | <0.25 | >2,048† | 16 | >32 |
| 90P | >64 | >16† | 32 | 512 | >2,048 | <0.25 | 128† | 16 | >32 |
| 122U | 64 | 4 | >32 | 64† | >2,048 | <0.25 | 128† | 16 | >32 |
| 122P | >64 | 4 | >32 | 1,024† | >2,048 | <0.25 | >2,048† | 16 | >32 |
| 186U | 4 | 4 | >32† | <16 | <128 | <0.25 | <64 | 16 | >32† |
| 186P | 4 | 8 | <0.5† | <16 | <128 | <0.25 | <64 | 16 | <1† |
| 191U | 32 | 4 | >32 | >1,024 | >2,048 | <0.25 | >2,048 | 16 | 32† |
| 191P | 64 | 8 | >32 | 512 | >2,048 | <0.25 | >2,048 | 16 | <1† |
| 204U | 64† | 4 | >32† | >1,024† | >2,048† | <0.25† | >2,048† | 16† | 32 |
| 204P | 4† | 8 | 4† | <16† | <128† | 2† | <64† | 0.5† | 32 |
| 217U | 4 | 4 | <0.5 | 32 | <128 | <0.25 | 256 | 8 | <1 |
| 217P | 4 | 4 | <0.5 | <16 | <128 | <0.25 | 256 | 8 | <1 |
| 221U | 64 | 4 | <0.5 | <16† | <128 | <0.25 | 128 | 8 | >32 |
| 221P | 64 | 4 | 1 | 64† | <128 | <0.25 | 128 | 8 | >32 |
*CHL, chloramphenicol; DAP, daptomycin; ERY, erythromycin; GEN, gentamicin; KAN, kanamicin; MXF, moxifloxacin; STR, streptomycin; Q-D, quinupristin-dalfopristin; TET, tetracycline.
†>1 dilution difference between urine and poultry strain.
- Page created: June 11, 2012
- Page last updated: June 11, 2012
- Page last reviewed: June 11, 2012
- Centers for Disease Control and Prevention,
-
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)